Literature DB >> 5387730

Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease.

D G Nathan, R L Baehner, D K Weaver.   

Abstract

The leukocytes of patients with chronic granulomatous disease (CGD) may be identified by their failure to reduce Nitro Blue Tetrazolium (NBT) during phagocytosis. This reaction, normally detected in the phagocytic vacuole, is absent or delayed in CGD monocytes and eosinophils as well as in neutrophils, even though sonicates of normal and CGD leukocytes contain equal activities of a cyanide insensitive enzyme system capable of reduction of NBT in the presence of pyridine nucleotide. Enlargement of CGD phagocytic vacuoles appears to be inhibited. Histochemical estimates of the rate of release of alkaline phosphatase are normal in CGD cells. Peroxidase activity is released from CGD cells, but the rate appears to be somewhat slower than normal in some cases. The latter observation may be explained by the increased intensity of the peroxidase stain in resting and phagocytizing CGD cells. The severity of the defect in NBT reduction within the phagocytic vacuoles of the leukocytes of patients and carriers is more variable than was previously appreciated. Some female carriers have profoundly reduced dye reduction and others are nearly indistinguishable from normal. Three brothers with CGD demonstrated significant, albeit delayed, NBT reduction in phagocytic vacuoles during prolonged incubation of their leukocytes. No obvious relationship exists, however, between the rate of reduction of NBT in vacuoles and the clinical severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5387730      PMCID: PMC322426          DOI: 10.1172/JCI106156

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  ENZYMATIC BASIS OF THE RESPIRATORY STIMULATION DURING PHAGOCYTOSIS.

Authors:  R H CAGAN; M L KARNOVSKY
Journal:  Nature       Date:  1964-10-17       Impact factor: 49.962

2.  SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE.

Authors:  L S KAPLOW
Journal:  Blood       Date:  1965-08       Impact factor: 22.113

3.  A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes.

Authors:  B H LANDING; H S SHIRKEY
Journal:  Pediatrics       Date:  1957-09       Impact factor: 7.124

4.  A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females.

Authors:  D B Windhorst; B Holmes; R A Good
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

5.  Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

Authors:  B H Park; S M Fikrig; E M Smithwick
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

6.  A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood.

Authors:  W C Davis; H Huber; S D Douglas; H H Fudenberg
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

7.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

8.  Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants.

Authors:  B H Park; B M Holmes; G E Rodey; R A Good
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

9.  Degranulation of leukocytes in chronic granulomatous disease.

Authors:  R L Baehner; M J Karnovsky; M L Karnovsky
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

10.  THE PARTICULATE HYDROLASES OF MACROPHAGES. II. BIOCHEMICAL AND MORPHOLOGICAL RESPONSE TO PARTICLE INGESTION.

Authors:  Z A COHN; E WIENER
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

View more
  40 in total

1.  Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms.

Authors:  W D Biggar; S Buron; B Holmes
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

2.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

3.  Poly L-histidine. A potent stimulator of superoxide generation in human blood leukocytes.

Authors:  I Ginsburg; R Borinski; M Sadovnic; Y Eilam; K Rainsford
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

4.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

5.  Measurement of Candidacidal Activity of Specific Leukocyte Types in Mixed Cell Populations II. Normal and Chronic Granulomatous Disease Eosinophils.

Authors:  R I Lehrer
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

Review 6.  Reactive oxygen species in phagocytic leukocytes.

Authors:  John M Robinson
Journal:  Histochem Cell Biol       Date:  2008-07-03       Impact factor: 4.304

7.  [A method for the evaluation of nitroblue tetrazolium reduction in human platelets (author's transl)].

Authors:  W Fereberger; H Schenk; F P Robier; S Sailer
Journal:  Klin Wochenschr       Date:  1978-10-01

8.  Nitro blue tetrazolium staining: a morphological demonstration of superoxide in the rat retina.

Authors:  H Zhang; E Agardh; C D Agardh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

9.  Inhibition of human neutrophil oxidative metabolism and degranulation in vitro by nitroblue tetrazolium and vitamin E.

Authors:  J E Repine; G Rao; G D Beall; J G White
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

10.  Partial defect of neutrophil oxidative metabolism in Crohn's disease.

Authors:  H W Verspaget; M A Mieremet-Ooms; I T Weterman; A S Peña
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.